Business Description
FibroGen Inc
NAICS : 325412
SIC : 2834
ISIN : US31572Q8087
Compare
Compare
Traded in other countries / regions
FGEN.USAFGEN.Mexico1FG.Germany0IL8.UK IPO Date
2014-11-14Description
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.25 | |||||
| Equity-to-Asset | -0.34 | |||||
| Debt-to-Equity | -0.98 | |||||
| Debt-to-EBITDA | -0.56 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -6.67 | |||||
| Beneish M-Score | -1.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.2 | |||||
| 3-Year EBITDA Growth Rate | -71 | |||||
| 3-Year EPS without NRI Growth Rate | -52.2 | |||||
| 3-Year FCF Growth Rate | -26.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.7 | |||||
| 9-Day RSI | 68.69 | |||||
| 14-Day RSI | 59.32 | |||||
| 6-1 Month Momentum % | -96.38 | |||||
| 12-1 Month Momentum % | -96.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.54 | |||||
| Cash Ratio | 0.91 | |||||
| Days Inventory | 813.65 | |||||
| Days Sales Outstanding | 50.2 | |||||
| Days Payable | 609.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.4 | |||||
| Shareholder Yield % | -30.41 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.15 | |||||
| Operating Margin % | -181.42 | |||||
| Net Margin % | -189.81 | |||||
| FCF Margin % | -227 | |||||
| ROA % | -53.82 | |||||
| ROIC % | -196.54 | |||||
| ROC (Joel Greenblatt) % | -297.95 | |||||
| ROCE % | -91.94 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.4 | |||||
| EV-to-EBIT | -0.09 | |||||
| EV-to-EBITDA | -0.1 | |||||
| EV-to-Revenue | 0.17 | |||||
| EV-to-FCF | -0.07 | |||||
| Earnings Yield (Greenblatt) % | -1111.11 | |||||
| FCF Yield % | -644.93 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:FGEN
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
FibroGen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 154.981 | ||
| EPS (TTM) ($) | -3.06 | ||
| Beta | 0.01 | ||
| Volatility % | 115.05 | ||
| 14-Day RSI | 59.32 | ||
| 14-Day ATR ($) | 0.081548 | ||
| 20-Day SMA ($) | 0.502485 | ||
| 12-1 Month Momentum % | -96.07 | ||
| 52-Week Range ($) | 0.3333 - 25.69 | ||
| Shares Outstanding (Mil) | 98.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FibroGen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FibroGen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
FibroGen Inc Frequently Asked Questions
What is FibroGen Inc(FGEN)'s stock price today?
The current price of FGEN is $0.55. The 52 week high of FGEN is $25.69 and 52 week low is $0.33.
When is next earnings date of FibroGen Inc(FGEN)?
The next earnings date of FibroGen Inc(FGEN) is 2024-02-27 Est..
Does FibroGen Inc(FGEN) pay dividends? If so, how much?
FibroGen Inc(FGEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers